Cysteine sulfinic acid decarboxylase

BE0000079ProteinHumansCSAD

Catalyzes the decarboxylation of L-aspartate, 3-sulfino-L-alanine (cysteine sulfinic acid), and L-cysteate to beta-alanine, hypotaurine and taurine, respectively. It is acted on by 2 drugs in DrugBank.

Gene name
CSAD
UniProtKB entry
Q9Y600Swiss-Prot
Residues / weight
493 residues · 55,023 Da
Also known as
4.1.1.29 · Aspartate 1-decarboxylase · CSD · Cysteine-sulfinate decarboxylase · Sulfinoalanine decarboxylase

Resolves to

Protein
UniProtQ9Y600UniProt nameCSAD_HUMAN
Gene
HGNCHGNC:18966NCBI Gene51380GenBank4894558GeneCardsCSAD
Pharmacology
KEGGhsa:51380
Structure
PDB2JIS
Drugs

What you can answer from here — as of September 07, 2019

2DrugsApproved to experimental, with action, bond type and pharmacological action
Sign in
3GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which approved drugs act on Cysteine sulfinic acid decarboxylase, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In